1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Primary Gout: new trials by email Literature Review of Primary Gout trials Research Report on Primary Gout
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia Febuxostat 20MG Tablets, Febuxostat 20MG Placebo, AR882 25MG - Primary Gout, Hyperuricemia | Phase 2 / Phase 3 | Unknown | Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd | 636 | 2024-04-22 | 2024-09-19 |
Gout (1) · Hyperuricemia (1)
Arthritis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Crystal Arthropathies (1) · Genetic Diseases, Inborn (1) · Joint Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Purine-Pyrimidine Metabolism, Inborn Errors (1) · Rheumatic Diseases (1)
Febuxostat (1)
Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd (1)
China (1)